Celularity Inc (CELU)
3.37
-0.09
(-2.60%)
USD |
NASDAQ |
May 28, 16:00
3.37
0.00 (0.00%)
After-Hours: 16:17
Celularity Shareholders Equity (Quarterly): 30.25M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 30.25M |
| June 30, 2023 | 118.50M |
| March 31, 2023 | 155.63M |
| December 31, 2022 | 198.90M |
| September 30, 2022 | 164.24M |
| June 30, 2022 | 150.15M |
| Date | Value |
|---|---|
| March 31, 2022 | 89.90M |
| December 31, 2021 | 99.42M |
| September 30, 2021 | 96.22M |
| June 30, 2021 | 80.96M |
| December 31, 2020 | -531.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-531.40M
Minimum
Dec 2020
198.90M
Maximum
Dec 2022
59.34M
Average
99.42M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 157.19M |
| Total Liabilities (Quarterly) | 126.94M |
| Debt to Equity Ratio | 1.157 |
| Current Ratio | 0.1949 |
| Net Debt Paydown Yield | -16.28% |